Trial Profile
A 25 Week, Open Label Study to Determine the Effects of Nebivolol When Added to Hydrochlorothiazide on Diastolic Function and Arterial Stiffness in African Americans With Hypertension.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 May 2011
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms NASAA
- Sponsors InVasc Therapeutics
- 06 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Nov 2009 New trial record